The Journal of Immunology, Vol 140, Issue 8 2569-2578, Copyright © 1988 by American Association of Immunologists

ARTICLES

T cell autoreactivity to insulin in diabetic and related non-diabetic individuals

P Naquet, J Ellis, D Tibensky, A Kenshole, B Singh, R Hodges and TL Delovitch
Banting and Best Department of Medical Research, University of Toronto, Canada.

T cell autoreactivity to insulin in type I diabetic and related non- diabetic individuals was analyzed. Peripheral T lymphocytes from both insulin-treated diabetic and untreated non-diabetic members of four families were found to proliferate in vitro in response to human insulin. T cell autoreactivity to insulin therefore does not appear to be diagnostic of the onset of type I diabetes. Highest T cell responses to human insulin were usually detected in insulin-dependent type I diabetes patients treated with a mixture of beef and pork insulin than with self insulin, the greater the dose of animal insulin the higher the T cell response. The T cell repertoires for self insulin appear to be similar in diabetics and non-diabetics based on their patterns of T cell reactivity to beef insulin, port insulin, human insulin, and various peptide of human insulin. The autoreactive T cells analyzed recognize two conformational epitopes of human insulin formed by interactions between A chain and B chain residues. One epitope is associated with the A chain loop and is present in the A1-A14/B1-B16 peptide, and the other epitope consists mainly of B chain residues located in the A16-A21/B10-B25 peptide. These two epitopes are present in amphipathic alpha-helical regions of insulin. HLA-DR (DR3, DR4, and DR5) and HLA-DQ (DQw2/DQw3) Ag can restrict these T cell responses to human insulin epitopes. The ability to detect insulin-specific autoreactive T cells in healthy non-diabetic individuals supports the hypothesis that autoreactive lymphocytes do not necessarily elicit autoimmune disease if present in an environment in which their activity is immunoregulated.

This article has been cited by other articles:

				S. E. Fineberg, T. T. Kawabata, D. Finco-Kent, R. J. Fountaine, G. L. Finch, and A. S. Krasner Immunological Responses to Exogenous Insulin Endocr. Rev., October 1, 2007; 28(6): 625 - 652. [Abstract] [Full Text] [PDF]

				M. Tiittanen, J. T. Huupponen, M. Knip, and O. Vaarala Insulin Treatment in Patients With Type 1 Diabetes Induces Upregulation of Regulatory T-Cell Markers in Peripheral Blood Mononuclear Cells Stimulated With Insulin In Vitro Diabetes, December 1, 2006; 55(12): 3446 - 3454. [Abstract] [Full Text] [PDF]

				A. Toma, S. Haddouk, J.-P. Briand, L. Camoin, H. Gahery, F. Connan, D. Dubois-Laforgue, S. Caillat-Zucman, J.-G. Guillet, J.-C. Carel, et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients PNAS, July 26, 2005; 102(30): 10581 - 10586. [Abstract] [Full Text] [PDF]

				S. Lindley, C. M. Dayan, A. Bishop, B. O. Roep, M. Peakman, and T. I.M. Tree Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes Diabetes, January 1, 2005; 54(1): 92 - 99. [Abstract] [Full Text] [PDF]

				T. I.M. Tree, G. Duinkerken, S. Willemen, R. R.P. de Vries, and B. O. Roep HLA-DQ-Regulated T-Cell Responses to Islet Cell Autoantigens Insulin and GAD65 Diabetes, July 1, 2004; 53(7): 1692 - 1699. [Abstract] [Full Text] [PDF]

				M A Kelly, M L Rayner, C H Mijovic, and A H Barnett Molecular aspects of type 1 diabetes Mol. Pathol., February 1, 2003; 56(1): 1 - 10. [Abstract] [Full Text] [PDF]

				W. Chen, I. Bergerot, J. F. Elliott, L. C. Harrison, N. Abiru, G. S. Eisenbarth, and T. L. Delovitch Evidence That a Peptide Spanning the B-C Junction of Proinsulin Is an Early Autoantigen Epitope in the Pathogenesis of Type 1 Diabetes J. Immunol., November 1, 2001; 167(9): 4926 - 4935. [Abstract] [Full Text] [PDF]

				T. Kamradt and N. A. Mitchison Tolerance and Autoimmunity N. Engl. J. Med., March 1, 2001; 344(9): 655 - 664. [Full Text] [PDF]

				L. Geng, M. Solimena, R. A. Flavell, R. S. Sherwin, and A. C. Hayday Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease PNAS, August 18, 1998; 95(17): 10055 - 10060. [Abstract] [Full Text] [PDF]